Advertisement
Table 2 MRDO-Screening strategy
| MRSA | 4MRGN | VRE | ESBL | ||||
|---|---|---|---|---|---|---|---|
| Universal screening * | Risk-based ** | Only admission to critical wards | Not reported | Admission screening | |||
| Tertiary (n = 45) | 2 (4.4 %) | 35 (77.8 %) | 4 (8.9 %) | 4 (8.9 %) | 30 (66.7 %) | 19 (42.2 %) | 15 (33.3 %) |
| Secondary (n = 76) | 6 (7.9 %) | 58 (76.3 %) | 3 (3.9 %) | 9 (11.8 %) | 34 (44.7 %) | 18 (23.7 %) | 19 (25.0 %) |
| Primary (n = 208) | 14 (6.7 %) | 168 (80.8 %) | 3 (1.4 %) | 23 (11.1 %) | 62 (29.8 %) | 32 (15.4 %) | 38 (18.3 %) |
| total (n = 329) | 22 (6.7 %) | 261 (79.3 %) | 10 (3.0 %) | 36 (10.9 %) | 126 (38.3 %) | 69 (21.0 %) | 72 (21.9 %) |
